High GPER1 expression levels were found to be significantly associated with poor relapse-free survival in women with stage 3 or 4 CRC indicating a role of GPER1 in CRC progression and survival, potentially as a result of estrogen-dependent signaling in CRC (29). The gene discussed is GPER1; the disease is colorectal carcinoma.